Preliminary evaluation of 2-[4-[3-(tert-butylamino)-2- hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)quinazolinone ([±]HX-CH 44) as a selective β1-adrenoceptor ligand for PET

Nuclear Medicine and Biology

Volumn 26, Issue 1, 1999, Pages 105-109

  Valette, Héric ^a   Dollé, Frédéric ^a   Guenther, Ilonka ^a   Demphel, Stéphane ^a   Rasetti, Christine ^a   Hinnen, Françoise ^a   Fuseau, Chantal ^a   Crouzel, Christian ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

1 antagonist; adrenoceptor; ( )HX CH 44; Carbon 11; Myocardium; PET

Indexed keywords

2 [4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY)PHENYL] 6 METHOXY 3 METHYL 4(3H) QUINAZOLINONE; BETA 1 ADRENERGIC RECEPTOR; CARBON 11; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG SYNTHESIS; DRUG UPTAKE; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOCHEMISTRY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBON RADIOISOTOPES; DOGS; HEART; LIGANDS; LUNG; PROPANOLAMINES; QUINAZOLINONES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032942673     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00073-0     Document Type: Article

References (24)

1. Berridge M.S., Nelson A.D., Zheng L., Leisure G.P., Miraldi F. Specific beta-adrenergic receptor binding of carazolol measured with PET. J. Nucl. Med. 35:1994;1665-1676.
2. Bilski A.J., Halliday S.E., Fitzgerald J.D., Wale J.L. The pharmacology of a selective β2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol. 5:1983;430-435.
3. Bristow M.R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P. β1 and β2-Adrenergic subpopulations in non-failing and failing human ventricle myocardium Coupling of both receptor subtypes to muscle contraction and selective β1 receptor downregulation in heart failure . Circ. Res. 59:1986;297-309.
4. Brodde O.E. β1- and β2-Adrenoceptors in the human heart Properties, function and alterations in chronic heart failure . Pharmacol. Rev. 43:1991;203-225.
5. Conway P. G., Tejani-Butt S. and Brunsswick D. J. (1987) Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo. J. Pharmacol. Exp. Ther. 241, 755-762.
6. 11C]methyl-iodide. Appl. Radiat. Isot. 38:1987;601-603.
7. Daemmgen J.W., Engelhardt G., Pelzer H. Pharmacological properties of an extremely selective β1-adrenoceptor antagonist, 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)- quinazolinone ((±)HX-CH 44 BS). Arzneim. Forsch. Drug. Res. 35:1985;383-390.
8. 18F]fluorometoprolol as a potential tracer for the visualization of β-adrenoceptors with PET. Nucl. Med. Biol. 20:1993;637-642.
9. Delforge J., Syrota A., Lançon J.P., Nakajima K., Loc'h C., Janier M., Vallois J.M., Cayla J., Crouzel C. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177 and a new graphical method. J. Nucl. Med. 32:1991;739-748.
10. Dooley D.J., Bittiger H., Reymann N.C. CGP 20712A A useful tool for quantitating β1 and β2 adrenoceptors . Eur. J. Pharmacol. 130:1986;137-139.
11. Elsinga P.H., van Waarde A., Visser G.M., Vaalburg W. Synthesis and preliminary evaluation of (R,S)-1-(2-((carbamoyl-4-hydroxy)phenoxy)-ethylamino)-3-(4-(11C)-methyl-4- trifluoro-methyl-2-imidazolyl)phenoxy)-2-propanol [11C]CGP 20712A) as a selective β1-adrenoceptor ligand for PET. Nucl. Med. Biol. 21:1994;211-217.
12. Garvey H.L., Ram N. Comparative antihypertensive effects and tissue distribution of beta-adrenergic blocking drugs. J. Pharmacol. Exp. Ther. 194:1975;220-223.
13. 3H]CGP12177. Biochem. J. 216:1983;669-674.
14. Lammertsma A.A., Boyd H., Patsalos P.N., Nihoyannopoulos P., Oakley C.M., Jones T., Camici P.G. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy A study with positron emission tomography . J. Am. Coll. Cardiol. 22:1993;1653-1660.
15. Law M.P. Demonstration of the suitability of CGP 12177 for in vivo studies of β-adrenoceptors. Br. J. Pharmacol. 109:1993;1101-1109.
16. Le Breton C., Crouzel C., Bonnot S., Prenant C. The use of sonication in reactions involving short live radioisotopes. J. Label. Compd. Radiopharm. 30:1991;174-175.
17. 3H-ICI 118,551 and blocking potency of ICI 118,551. Nauyn. Schmeideberg's Arch. Pharmacol. 331, 40-51.
18. Mason R.P., Rhodes D.G., Herbette L.G. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes. J. Med. Chem. 34:1991;869-877.
19. Mauz A.B.M., Pelzer H. β-Adrenoceptor-binding studies of the cardioselective β-blockers bisoprolol, H-I 42 BS and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats Two β1-binding sites for bisoprolol . J. Cardiovasc. Pharmacol. 15:1990;421-427.
20. 11C-CGP12177. Circulation. 87:1993;1169-1178.
21. 3H]CGP 12177 for resolving subtype selectivity of competitive ligands. Naunyn. Schmiedeberg's Arch. Pharmacol. 336:1987;519-525.
22. Staehelin M., Hertel C. 3H-CGP 12177 A hydrophilic β-adrenergic ligand suitable for measuring cell surface receptors . J. Receptor. Res. 3:1983;35-43.
23. van Waarde A., Meeder J.G., Blanksma P.K., Bouwer J., Visser G.M., Elsinga P.H., Paans A.M.J., Vaalburg W., Lie K.I. Suitability of CGP 12177 and CGP 26505 for quantitative imaging of β-adrenoceptors. Nucl. Med. Biol. 19:1992;711-718.
24. van Waarde A., Meeder J.G., Blanksma P.K., Brodde O.E., Visser G.M., Elsinga P.H., Paans A.M.J., Vaalburg W., Lie K.I. Uptake of radioligands by rat heart and lung in vivo CGP 12177 does and CGP 26505 does not reflect binding to β-adrenoceptors . Eur. J. Pharmacol. 222:1992;107-112.